Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-Masked, Randomized, Multi-Center Phase 2 Study to Evaluate the Efficacy and Safety of Lacripep™ in Subjects With Dry Eye Associated With Primary Sjögren's Syndrome

NCT03226444 is registered in ClinicalTrials.gov with TearSolutions, Inc. as lead sponsor.

NCT NCT03226444
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03226444 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-Masked, Randomized, Multi-Center Phase 2 Study to Evaluate the Efficacy and Safety of Lacripep™ in Subjects With Dry Eye Associated With Primary Sjögren's Syndrome
Lead sponsor
TearSolutions, Inc.
Phase
Phase 1/2
Overall status
Completed
Start date
June 30, 2017
Completion date
December 27, 2019
Enrollment
204 (actual)
Sites
35

Conditions

As the registry lists them; a condition with its own page is linked.

dry eye, primary sjögren syndrome